SGX Pharmaceuticals announced that it will present data today at the American Society of Hematology's 47th Annual Meeting and Exposition showing that compounds discovered by applying its FAST(TM) lead discovery platform potently inhibit wild-type and Gleevec-resistant BCR-ABL, including the most clinically challenging mutation T315I.

SGX Pharmaceuticals Presenting Data at American Society of Hematology Annual Meeting on Inhibitors of Wild-Type and Gleevec(R)-Resistant BCR-ABL Kinas

 


New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com

Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com

CML (Chronic Myelogenous Leukemia Support List)
---------------------------------
Part Of CMLHope.Com
An International Community Of CML Patients
For more information: http://cmlhope.com

Post Message: cml@yahoogroups.com
Subscribe:  [EMAIL PROTECTED]
Unsubscribe:  [EMAIL PROTECTED]
Change To No Mail/Web: [EMAIL PROTECTED]
Change To Digest: [EMAIL PROTECTED]
Change To Email: [EMAIL PROTECTED]
List Help: [EMAIL PROTECTED] 
CML Group Web Site http://groups.yahoo.com/group/CML




SPONSORED LINKS
Chronic myelogenous leukemia Leukemia treatment Cml


YAHOO! GROUPS LINKS




Reply via email to